HIV, Opioid Dependence
Conditions
Keywords
Methadone-maintenance, HIV, Risk behavior, Injection drug use, Condom use, Health care participation, Opioid replacement therapy
Brief summary
To conduct a randomized clinical trial (RCT) of a community-friendly behavioral intervention designed to reduce HIV risk behavior among injection drug users (IDUs) in drug treatment by comparing risk-behavior outcomes of four weekly intervention sessions with a time-and-attention-matched control condition.
Detailed description
This research study will test the effects of CHRP, a community-friendly risk reduction intervention, which is based on the Information-Motivation-Behavioral Skills model of health behavior change (IMB; Fisher & Fisher, 1992), and, thus, is designed to enhance knowledge, motivation, and behavior skills for reducing drug- and sex-related HIV risk behaviors. Outcomes assessed will include urine toxicology screens, self-reported HIV drug- and sex-related HIV risk behavior, HIV/AIDS knowledge, risk reduction motivation, and risk reduction behavioral skills. To measure the effects of CHRP, the investigators are proposing a two-condition (standard of care plus the CHRP intervention vs. standard of care plus a time-and-attention matched control condition) randomized design, balancing for participant gender. The investigators will assess participants at baseline, immediately post-intervention (i.e., at 4 weeks), and at 3-, 6-, and 12-month measurement points following the intervention. This assessment approach will allow the investigators to examine the trajectory of HIV risk reduction change including the decay or emergence of intervention effects.
Interventions
Four weekly HIV risk-reduction groups and routine clinical services (i.e., daily methadone and case management).
BEHAVIORALTime-and-Attention-Matched Control Condition
Four weekly support groups and routine clinical services (i.e., daily methadone and case management).
Sponsors
University of Connecticut
National Institute on Drug Abuse (NIDA)
APT Foundation, Inc.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* At least 18 years of age * Opioid-dependent and seeking methadone maintenance treatment * Report drug- or sex-related HIV risk behavior in previous 6 months * Able to read and understand the questionnaires, Audio Computer Assisted Self Interview (ACASI), and consent form * Available for the full duration of the study with no anticipated circumstances impeding participation (e.g., jail term) * Not actively suicidal, homicidal, or psychotic as assessed by trained research staff under the supervision of a licensed clinical psychologist
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Baseline | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. |
| Female Condom Skills (0-100%) | Baseline | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. |
| Male Condom Skills (0-100%) | Baseline | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. |
| Condom Use (0-4) | Baseline | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. |
| Sex-related HIV-risk Reduction Knowledge (0-1) | Baseline | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. |
| Demonstrated Drug Risk Reduction Skills (0-100%) | Baseline | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. |
| Safer Drug Use (0-4) | Baseline | Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. |
| Drug-related HIV-risk Reduction Knowledge (0-1) | Baseline | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge). |
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Baseline | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. |
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Baseline | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. |
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Baseline | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. |
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Baseline | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. |
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Baseline | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORMichael C Copenhaver, Ph.D.
University of Connecticut
Participant flow
Recruitment details
A total of 648 participants were screened from March 2007 through August 2010 from a methadone maintenance program in New Haven, Connecticut.
Pre-assignment details
292 participants did not meet the study's inclusion criteria, 36 participants missed the initial interview appointment, and 16 participants were ineligible due to already being enrolled in another study.
Participants by arm
| Arm | Count |
|---|---|
| CHRP Group Patients assigned to Community-friendly Health Recovery Program (CHRP) will receive a weekly HIV risk reduction group level intervention led by two facilitators trained and supervised by the PI, a licensed clinical psychologist. The CHRP intervention is a substantially shortened version of the comprehensive Holistic Health Recovery Program (HHRP)-based interventions that have been identified as demonstrating evidence of effectiveness in two randomized clinical trials. The CHRP, which includes four 50-minute groups (1 group per week), will contain only content that relates explicitly to drug- or sex-related HIV risk reduction. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management).
Community-friendly Health Recovery Program : Four weekly HIV risk-reduction groups and routine clinical services (i.e., daily methadone and case management). | 149 |
| Control Condition The time-and-attention-matched control condition for the proposed research will be a time and contact-matched, non-contaminating support group for individuals in recovery modeled after similar groups offered in the community. There will be no overlap between the content of the comparison intervention and experimental intervention although the basic structure will be the same. Thus, each participant will be asked to attend four 50-minute weekly group sessions led by two trained facilitators. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management).
Time-and-Attention-Matched Control Condition : Four weekly support groups and routine clinical services (i.e., daily methadone and case management). | 155 |
| Total | 304 |
Baseline characteristics
| Characteristic | Control Condition | CHRP Group | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 155 Participants | 149 Participants | 304 Participants |
| Age, Continuous | 33.50 years STANDARD_DEVIATION 9.141 | 34.26 years STANDARD_DEVIATION 9.939 | 33.87 years STANDARD_DEVIATION 9.532 |
| Region of Enrollment United States | 155 participants | 149 participants | 304 participants |
| Sex: Female, Male Female | 81 Participants | 76 Participants | 157 Participants |
| Sex: Female, Male Male | 74 Participants | 73 Participants | 147 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| other Total, other adverse events | 0 / 149 | 0 / 155 |
| serious Total, serious adverse events | 0 / 149 | 0 / 155 |
Outcome results
Primary
Condom Use (0-4)
Participants were asked: In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex? and rated on scale of 0 to 4, with indicating greater condom use.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Condom Use (0-4) | 3.80 units on a scale | Standard Error 0.24 |
| Control Condition | Condom Use (0-4) | 3.56 units on a scale | Standard Error 0.26 |
Primary
Condom Use (0-4)
Participants were asked: In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex? and rated on scale of 0 to 4, with indicating greater condom use.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Condom Use (0-4) | 3.61 units on a scale | Standard Error 0.24 |
| Control Condition | Condom Use (0-4) | 3.56 units on a scale | Standard Error 0.26 |
Primary
Condom Use (0-4)
Participants were asked: In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex? and rated on scale of 0 to 4, with indicating greater condom use.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Condom Use (0-4) | 3.95 units on a scale | Standard Error 0.24 |
| Control Condition | Condom Use (0-4) | 3.75 units on a scale | Standard Error 0.25 |
Primary
Condom Use (0-4)
Participants were asked: In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex? and rated on scale of 0 to 4, with indicating greater condom use.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Condom Use (0-4) | 3.65 units on a scale | Standard Error 0.24 |
| Control Condition | Condom Use (0-4) | 3.79 units on a scale | Standard Error 0.25 |
Primary
Condom Use (0-4)
Participants were asked: In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex? and rated on scale of 0 to 4, with indicating greater condom use.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Condom Use (0-4) | 3.73 units on a scale | Standard Error 0.24 |
| Control Condition | Condom Use (0-4) | 3.83 units on a scale | Standard Error 0.25 |
Primary
Demonstrated Drug Risk Reduction Skills (0-100%)
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Demonstrated Drug Risk Reduction Skills (0-100%) | 72.61 Percentage of correct steps | Standard Error 1.91 |
| Control Condition | Demonstrated Drug Risk Reduction Skills (0-100%) | 63.63 Percentage of correct steps | Standard Error 2.01 |
Primary
Demonstrated Drug Risk Reduction Skills (0-100%)
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Demonstrated Drug Risk Reduction Skills (0-100%) | 40.60 Percentage of correct steps | Standard Error 1.99 |
| Control Condition | Demonstrated Drug Risk Reduction Skills (0-100%) | 42.75 Percentage of correct steps | Standard Error 2.09 |
Primary
Demonstrated Drug Risk Reduction Skills (0-100%)
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Demonstrated Drug Risk Reduction Skills (0-100%) | 76.37 Percentage of correct steps | Standard Error 2.03 |
| Control Condition | Demonstrated Drug Risk Reduction Skills (0-100%) | 53.11 Percentage of correct steps | Standard Error 2.14 |
Primary
Demonstrated Drug Risk Reduction Skills (0-100%)
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Demonstrated Drug Risk Reduction Skills (0-100%) | 69.59 Percentage of correct steps | Standard Error 2.04 |
| Control Condition | Demonstrated Drug Risk Reduction Skills (0-100%) | 60.34 Percentage of correct steps | Standard Error 2.15 |
Primary
Demonstrated Drug Risk Reduction Skills (0-100%)
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Demonstrated Drug Risk Reduction Skills (0-100%) | 74.12 Percentage of correct steps | Standard Error 1.97 |
| Control Condition | Demonstrated Drug Risk Reduction Skills (0-100%) | 63.12 Percentage of correct steps | Standard Error 2.07 |
Primary
Drug-related HIV-risk Reduction Knowledge (0-1)
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles) and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Drug-related HIV-risk Reduction Knowledge (0-1) | 0.96 units on a scale | Standard Error 0.02 |
| Control Condition | Drug-related HIV-risk Reduction Knowledge (0-1) | 1.00 units on a scale | Standard Error 0.02 |
Primary
Drug-related HIV-risk Reduction Knowledge (0-1)
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles) and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Drug-related HIV-risk Reduction Knowledge (0-1) | 1.00 units on a scale | Standard Error 0.01 |
| Control Condition | Drug-related HIV-risk Reduction Knowledge (0-1) | 0.98 units on a scale | Standard Error 0.01 |
Primary
Drug-related HIV-risk Reduction Knowledge (0-1)
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles) and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Drug-related HIV-risk Reduction Knowledge (0-1) | 1.00 units on a scale | Standard Error 0.01 |
| Control Condition | Drug-related HIV-risk Reduction Knowledge (0-1) | 0.96 units on a scale | Standard Error 0.01 |
Primary
Drug-related HIV-risk Reduction Knowledge (0-1)
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles) and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge).
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Drug-related HIV-risk Reduction Knowledge (0-1) | 0.96 units on a scale | Standard Error 0.02 |
| Control Condition | Drug-related HIV-risk Reduction Knowledge (0-1) | 0.99 units on a scale | Standard Error 0.02 |
Primary
Drug-related HIV-risk Reduction Knowledge (0-1)
Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles).
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Drug-related HIV-risk Reduction Knowledge (0-1) | 0.98 units on a scale | Standard Error 0.02 |
| Control Condition | Drug-related HIV-risk Reduction Knowledge (0-1) | 0.96 units on a scale | Standard Error 0.02 |
Primary
Female Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Female Condom Skills (0-100%) | 83.37 percentage of correct steps | Standard Error 1.19 |
| Control Condition | Female Condom Skills (0-100%) | 82.19 percentage of correct steps | Standard Error 1.25 |
Primary
Female Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Female Condom Skills (0-100%) | 83.03 percentage of correct steps | Standard Error 1.19 |
| Control Condition | Female Condom Skills (0-100%) | 80.86 percentage of correct steps | Standard Error 1.26 |
Primary
Female Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Female Condom Skills (0-100%) | 79.29 percentage of correct steps | Standard Error 1.38 |
| Control Condition | Female Condom Skills (0-100%) | 79.07 percentage of correct steps | Standard Error 1.45 |
Primary
Female Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Female Condom Skills (0-100%) | 82.54 percentage of correct steps | Standard Error 1.25 |
| Control Condition | Female Condom Skills (0-100%) | 74.32 percentage of correct steps | Standard Error 1.31 |
Primary
Female Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Female Condom Skills (0-100%) | 57.60 percentage of correct steps | Standard Error 1.69 |
| Control Condition | Female Condom Skills (0-100%) | 59.38 percentage of correct steps | Standard Error 1.78 |
Primary
Male Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Male Condom Skills (0-100%) | 71.63 percentage of correct steps | Standard Error 1.35 |
| Control Condition | Male Condom Skills (0-100%) | 73.97 percentage of correct steps | Standard Error 1.42 |
Primary
Male Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Male Condom Skills (0-100%) | 87.23 percentage of correct steps | Standard Error 1.4 |
| Control Condition | Male Condom Skills (0-100%) | 82.71 percentage of correct steps | Standard Error 1.47 |
Primary
Male Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Male Condom Skills (0-100%) | 85.01 percentage of correct steps | Standard Error 1.22 |
| Control Condition | Male Condom Skills (0-100%) | 84.64 percentage of correct steps | Standard Error 1.28 |
Primary
Male Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Male Condom Skills (0-100%) | 87.51 percentage of correct steps | Standard Error 1.04 |
| Control Condition | Male Condom Skills (0-100%) | 87.64 percentage of correct steps | Standard Error 1.09 |
Primary
Male Condom Skills (0-100%)
Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Male Condom Skills (0-100%) | 86.70 percentage of correct steps | Standard Error 1.17 |
| Control Condition | Male Condom Skills (0-100%) | 85.95 percentage of correct steps | Standard Error 1.24 |
Primary
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., I plan to always use clean needles if I shoot up drugs during the next six months) and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.79 units on a scale | Standard Error 0.05 |
| Control Condition | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.85 units on a scale | Standard Error 0.05 |
Primary
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., I plan to always use clean needles if I shoot up drugs during the next six months) and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.88 units on a scale | Standard Error 0.04 |
| Control Condition | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.92 units on a scale | Standard Error 0.04 |
Primary
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., I plan to always use clean needles if I shoot up drugs during the next six months) and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.87 units on a scale | Standard Error 0.06 |
| Control Condition | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.78 units on a scale | Standard Error 0.06 |
Primary
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., I plan to always use clean needles if I shoot up drugs during the next six months) and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.87 units on a scale | Standard Error 0.06 |
| Control Condition | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.86 units on a scale | Standard Error 0.07 |
Primary
Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., I plan to always use clean needles if I shoot up drugs during the next six months) and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.91 units on a scale | Standard Error 0.05 |
| Control Condition | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.83 units on a scale | Standard Error 0.05 |
Primary
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., Always using condoms during sexual intercourse during the next three months would be good) and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.21 units on a scale | Standard Error 0.09 |
| Control Condition | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.22 units on a scale | Standard Error 0.09 |
Primary
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., Always using condoms during sexual intercourse during the next three months would be good) and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.20 units on a scale | Standard Error 0.09 |
| Control Condition | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.26 units on a scale | Standard Error 0.09 |
Primary
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., Always using condoms during sexual intercourse during the next three months would be good) and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.41 units on a scale | Standard Error 0.08 |
| Control Condition | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.24 units on a scale | Standard Error 0.08 |
Primary
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., Always using condoms during sexual intercourse during the next three months would be good) and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.39 units on a scale | Standard Error 0.08 |
| Control Condition | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.24 units on a scale | Standard Error 0.09 |
Primary
Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., Always using condoms during sexual intercourse during the next three months would be good) and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.40 units on a scale | Standard Error 0.08 |
| Control Condition | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.29 units on a scale | Standard Error 0.08 |
Primary
Safer Drug Use (0-4)
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Safer Drug Use (0-4) | 3.84 units on a scale | Standard Error 0.05 |
| Control Condition | Safer Drug Use (0-4) | 3.77 units on a scale | Standard Error 0.05 |
Primary
Safer Drug Use (0-4)
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Safer Drug Use (0-4) | 3.78 units on a scale | Standard Error 0.06 |
| Control Condition | Safer Drug Use (0-4) | 3.79 units on a scale | Standard Error 0.06 |
Primary
Safer Drug Use (0-4)
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Safer Drug Use (0-4) | 3.83 units on a scale | Standard Error 0.05 |
| Control Condition | Safer Drug Use (0-4) | 3.81 units on a scale | Standard Error 0.05 |
Primary
Safer Drug Use (0-4)
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Safer Drug Use (0-4) | 3.25 units on a scale | Standard Error 0.1 |
| Control Condition | Safer Drug Use (0-4) | 3.39 units on a scale | Standard Error 0.1 |
Primary
Safer Drug Use (0-4)
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Safer Drug Use (0-4) | 3.87 units on a scale | Standard Error 0.05 |
| Control Condition | Safer Drug Use (0-4) | 3.85 units on a scale | Standard Error 0.05 |
Primary
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., How hard would it be for you to always use condoms) and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.38 units on a scale | Standard Error 0.08 |
| Control Condition | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.52 units on a scale | Standard Error 0.08 |
Primary
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., How hard would it be for you to always use condoms) and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.22 units on a scale | Standard Error 0.09 |
| Control Condition | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.45 units on a scale | Standard Error 0.1 |
Primary
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., How hard would it be for you to always use condoms) and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.42 units on a scale | Standard Error 0.08 |
| Control Condition | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.36 units on a scale | Standard Error 0.09 |
Primary
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., How hard would it be for you to always use condoms) and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.41 units on a scale | Standard Error 0.05 |
| Control Condition | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.38 units on a scale | Standard Error 0.09 |
Primary
Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., How hard would it be for you to always use condoms) and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.01 units on a scale | Standard Error 0.1 |
| Control Condition | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.00 units on a scale | Standard Error 0.11 |
Primary
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., If asked, I am confident I could demonstrate how to use male condom and female condoms correctly) and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.57 units on a scale | Standard Error 0.08 |
| Control Condition | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.70 units on a scale | Standard Error 0.08 |
Primary
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., If asked, I am confident I could demonstrate how to use male condom and female condoms correctly) and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 3.00 units on a scale | Standard Error 0.12 |
| Control Condition | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 3.09 units on a scale | Standard Error 0.13 |
Primary
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., If asked, I am confident I could demonstrate how to use male condom and female condoms correctly) and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 2.99 units on a scale | Standard Error 0.12 |
| Control Condition | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 3.06 units on a scale | Standard Error 0.13 |
Primary
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., If asked, I am confident I could demonstrate how to use male condom and female condoms correctly) and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 3.02 units on a scale | Standard Error 0.12 |
| Control Condition | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 3.14 units on a scale | Standard Error 0.12 |
Primary
Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., If asked, I am confident I could demonstrate how to use male condom and female condoms correctly) and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.75 units on a scale | Standard Error 0.07 |
| Control Condition | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.77 units on a scale | Standard Error 0.07 |
Primary
Sex-related HIV-risk Reduction Knowledge (0-1)
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Sex-related HIV-risk Reduction Knowledge (0-1) | 0.98 units on a scale | Standard Error 0.01 |
| Control Condition | Sex-related HIV-risk Reduction Knowledge (0-1) | 0.99 units on a scale | Standard Error 0.01 |
Primary
Sex-related HIV-risk Reduction Knowledge (0-1)
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Sex-related HIV-risk Reduction Knowledge (0-1) | 0.87 units on a scale | Standard Error 0.03 |
| Control Condition | Sex-related HIV-risk Reduction Knowledge (0-1) | 0.91 units on a scale | Standard Error 0.03 |
Primary
Sex-related HIV-risk Reduction Knowledge (0-1)
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Sex-related HIV-risk Reduction Knowledge (0-1) | 1.00 units on a scale | Standard Error 0.02 |
| Control Condition | Sex-related HIV-risk Reduction Knowledge (0-1) | 0.95 units on a scale | Standard Error 0.02 |
Primary
Sex-related HIV-risk Reduction Knowledge (0-1)
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Sex-related HIV-risk Reduction Knowledge (0-1) | 0.97 units on a scale | Standard Error 0.02 |
| Control Condition | Sex-related HIV-risk Reduction Knowledge (0-1) | 0.93 units on a scale | Standard Error 0.02 |
Primary
Sex-related HIV-risk Reduction Knowledge (0-1)
Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Sex-related HIV-risk Reduction Knowledge (0-1) | 0.97 units on a scale | Standard Error 0.02 |
| Control Condition | Sex-related HIV-risk Reduction Knowledge (0-1) | 0.95 units on a scale | Standard Error 0.02 |
Primary
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months) and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.65 units on a scale | Standard Error 0.08 |
| Control Condition | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.72 units on a scale | Standard Error 0.09 |
Primary
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months) and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.63 units on a scale | Standard Error 0.09 |
| Control Condition | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.75 units on a scale | Standard Error 0.09 |
Primary
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months) and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.73 units on a scale | Standard Error 0.07 |
| Control Condition | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.91 units on a scale | Standard Error 0.07 |
Primary
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months) and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.90 units on a scale | Standard Error 0.04 |
| Control Condition | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.85 units on a scale | Standard Error 0.05 |
Primary
Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months) and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.77 units on a scale | Standard Error 0.08 |
| Control Condition | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | 4.69 units on a scale | Standard Error 0.08 |
Primary
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., Most people who are important to me think I should always use condoms during sexual intercourse in the next three months) and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: Baseline
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.67 units on a scale | Standard Error 0.07 |
| Control Condition | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.81 units on a scale | Standard Error 0.08 |
Primary
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., Most people who are important to me think I should always use condoms during sexual intercourse in the next three months) and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: Immediately Post-Intervention, at 4 weeks
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.73 units on a scale | Standard Error 0.07 |
| Control Condition | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.75 units on a scale | Standard Error 0.07 |
Primary
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., Most people who are important to me think I should always use condoms during sexual intercourse in the next three months) and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 3-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.73 units on a scale | Standard Error 0.07 |
| Control Condition | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.71 units on a scale | Standard Error 0.07 |
Primary
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., Most people who are important to me think I should always use condoms during sexual intercourse in the next three months) and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 6-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.75 units on a scale | Standard Error 0.07 |
| Control Condition | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.77 units on a scale | Standard Error 0.07 |
Primary
Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5)
Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., Most people who are important to me think I should always use condoms during sexual intercourse in the next three months) and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior.
Time frame: 12-month follow up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CHRP Group | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.57 units on a scale | Standard Error 0.08 |
| Control Condition | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | 4.70 units on a scale | Standard Error 0.08 |